Akio Arakawa
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long-term safety and effectiveness of rimegepant for the preventive treatment of migraine in Japan: an open-label extension of a phase 3 study.
Journal: The journal of headache and pain
Published: December 17, 2025
Plain Language Summary Publication: Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial.
Journal: Headache
Published: September 21, 2025
Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial.
Journal: Headache
Published: January 23, 2025
Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose-ranging, double-blind, randomized controlled trial.
Journal: Headache
Published: November 28, 2024
Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.
Journal: Clinical drug investigation
Published: July 23, 2016
An investigation of factors contributing to higher levels of placebo response in clinical trials in neuropathic pain: a systematic review and meta-analysis.
Journal: Clinical drug investigation
Published: January 07, 2015
A Comparison of the Pharmacokinetics and Drug Safety Among East Asian Populations.
Journal: Therapeutic innovation & regulatory science
Published: May 01, 2014
Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.
Journal: Drug safety
Published: September 13, 2012
Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial.
Journal: Journal of diabetes investigation
Published: November 30, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026